| Rotigotine for restless legs syndrome. | |
| | |
MedLine Citation:
|
PMID: 19956807 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Restless legs syndrome (RLS) is a neurological disorder related to abnormal and unpleasant sensations and movements in the legs. It usually occurs at nighttime and thus has a detrimental impact on the ability to sleep, leading to poor patient quality of life. UCB has been developing rotigotine transdermal patch system (Neupro; SPM-962) as a treatment for RLS. This system is designed to replace levels of dopamine in the body via once-daily application of the patch, in a bid to restore proper motor functioning. The rotigotine patch has been authorized for the treatment of RLS since August 2008. |
| | |
Authors:
|
Shelley Davies |
Related Documents
:
|
1538457 - Toxic shock syndrome: a complication of continent urinary diversion. 8605437 - Myocarditis-associated ventricular fibrillation. an unusual cause of syncope in wolff-p... 20669297 - Thomas de quincey and his restless legs symptoms as depicted in "confessions of an engl... 15020537 - Malignant vasovagal syndrome in two patients with wolff-parkinson-white syndrome. 10447647 - Anomalies associated with axenfeld-rieger syndrome. 3284467 - Cutaneous angiomas in poems syndrome. an ultrastructural and immunohistochemical study. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Drugs of today (Barcelona, Spain : 1998) Volume: 45 ISSN: 1699-3993 ISO Abbreviation: Drugs Today Publication Date: 2009 Sep |
Date Detail:
|
Created Date: 2009-12-03 Completed Date: 2010-03-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101160518 Medline TA: Drugs Today (Barc) Country: Spain |
Other Details:
|
Languages: eng Pagination: 663-8 Citation Subset: IM |
Affiliation:
|
Medical Information Department, Thomson Reuters, Barcelona, Spain. scientific.prousjournals@thomsonreuters.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Cutaneous Dopamine Agonists / administration & dosage, pharmacology, therapeutic use* Dosage Forms Drug Evaluation, Preclinical Humans Randomized Controlled Trials as Topic Restless Legs Syndrome / drug therapy* Tetrahydronaphthalenes / administration & dosage, pharmacology, therapeutic use* Thiophenes / administration & dosage, pharmacology, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Dopamine Agonists; 0/Dosage Forms; 0/Tetrahydronaphthalenes; 0/Thiophenes; 92206-54-7/N 0437 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pazopanib for the treatment of renal cell carcinoma and other malignancies.
Next Document: Dapoxetine: A novel treatment for premature ejaculation.